PSAT Fundamental Analysis - PASSAT

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to PSAT. PSAT was compared to 12 industry peers in the Broadline Retail industry. While PSAT seems to be doing ok healthwise, there are quite some concerns on its profitability. PSAT does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PSAT was profitable.

In the past year PSAT has reported a negative cash flow from operations.

PSAT had positive earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: PSAT reported negative operating cash flow in multiple years.

1.2 Ratios

PSAT has a worse Return On Assets (1.68%) than 75.00% of its industry peers.

PSAT's Return On Equity of 2.77% is on the low side compared to the rest of the industry. PSAT is outperformed by 66.67% of its industry peers.

The Return On Invested Capital of PSAT (3.76%) is comparable to the rest of the industry.

Measured over the past 3 years, the Average Return On Invested Capital for PSAT is below the industry average of 9.59%.

		Industry Rank	Sector Rank
ROA	1.68%
ROE	2.77%
ROIC	3.76%

ROA(3y)3.75%

ROA(5y)3.66%

ROE(3y)5.84%

ROE(5y)5.33%

ROIC(3y)6.18%

ROIC(5y)6.63%

1.3 Margins

The Profit Margin of PSAT (1.84%) is worse than 75.00% of its industry peers.

PSAT's Profit Margin has declined in the last couple of years.

PSAT has a worse Operating Margin (4.43%) than 66.67% of its industry peers.

PSAT's Operating Margin has declined in the last couple of years.

PSAT's Gross Margin of 57.77% is amongst the best of the industry. PSAT outperforms 83.33% of its industry peers.

In the last couple of years the Gross Margin of PSAT has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	4.43%
PM (TTM)	1.84%
GM	57.77%

OM growth 3Y-10.04%

OM growth 5Y-4.36%

PM growth 3Y-1.4%

PM growth 5Y-17.24%

GM growth 3Y1.53%

GM growth 5Y0.6%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PSAT is destroying value.

Compared to 1 year ago, PSAT has less shares outstanding

Compared to 5 years ago, PSAT has less shares outstanding

Compared to 1 year ago, PSAT has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.99 indicates that PSAT is not in any danger for bankruptcy at the moment.

PSAT has a worse Altman-Z score (2.99) than 66.67% of its industry peers.

PSAT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.

PSAT has a better Debt to Equity ratio (0.20) than 83.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	N/A
Altman-Z	2.99

ROIC/WACC0.5

WACC7.48%

2.3 Liquidity

PSAT has a Current Ratio of 3.33. This indicates that PSAT is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 3.33, PSAT belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.

PSAT has a Quick Ratio of 2.28. This indicates that PSAT is financially healthy and has no problem in meeting its short term obligations.

PSAT has a Quick ratio of 2.28. This is amongst the best in the industry. PSAT outperforms 83.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.33
Quick Ratio	2.28

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PSAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.28%.

The Earnings Per Share has been decreasing by -7.94% on average over the past years.

The Revenue has decreased by -2.55% in the past year.

PSAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.13% yearly.

EPS 1Y (TTM)-47.28%

EPS 3Y14.36%

EPS 5Y-7.94%

EPS Q2Q%-10.54%

Revenue 1Y (TTM)-2.55%

Revenue growth 3Y15.78%

Revenue growth 5Y11.13%

Sales Q2Q%-1.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.83, PSAT is valued correctly.

PSAT's Price/Earnings ratio is a bit cheaper when compared to the industry. PSAT is cheaper than 75.00% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 27.02. PSAT is valued slightly cheaper when compared to this.

		Industry Rank	Sector Rank
PE	15.83
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PSAT indicates a rather cheap valuation: PSAT is cheaper than 100.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	1.32

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PSAT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PASSAT

EPA:PSAT (9/5/2025, 7:00:00 PM)

4.59

0 (0%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustryBroadline Retail

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners5.79%

Ins Owner ChangeN/A

Market Cap19.28M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	15.83
Fwd PE	N/A
P/S	0.31
P/FCF	N/A
P/OCF	N/A
P/B	0.47
P/tB	0.52
EV/EBITDA	1.32

EPS(TTM)0.29

EY6.32%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.65

FCFYN/A

OCF(TTM)-0.09

OCFYN/A

SpS14.84

BVpS9.83

TBVpS8.8

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.68%
ROE	2.77%
ROCE	5.45%
ROIC	3.76%
ROICexc	6.45%
ROICexgc	7.56%
OM	4.43%
PM (TTM)	1.84%
GM	57.77%
FCFM	N/A

ROA(3y)3.75%

ROA(5y)3.66%

ROE(3y)5.84%

ROE(5y)5.33%

ROIC(3y)6.18%

ROIC(5y)6.63%

ROICexc(3y)11.28%

ROICexc(5y)12.99%

ROICexgc(3y)12.56%

ROICexgc(5y)14.63%

ROCE(3y)8.95%

ROCE(5y)9.61%

ROICexcg growth 3Y-6.11%

ROICexcg growth 5Y-9.64%

ROICexc growth 3Y-8.19%

ROICexc growth 5Y-9.07%

OM growth 3Y-10.04%

OM growth 5Y-4.36%

PM growth 3Y-1.4%

PM growth 5Y-17.24%

GM growth 3Y1.53%

GM growth 5Y0.6%

F-Score3

Asset Turnover0.92

Health

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	N/A
Debt/EBITDA	1.6
Cap/Depr	93.3%
Cap/Sales	3.77%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.33
Quick Ratio	2.28
Altman-Z	2.99

F-Score3

WACC7.48%

ROIC/WACC0.5

Cap/Depr(3y)83.8%

Cap/Depr(5y)95.29%

Cap/Sales(3y)2.98%

Cap/Sales(5y)2.98%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-47.28%

EPS 3Y14.36%

EPS 5Y-7.94%

EPS Q2Q%-10.54%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.55%

Revenue growth 3Y15.78%

Revenue growth 5Y11.13%

Sales Q2Q%-1.92%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-11.45%

EBIT growth 3Y4.16%

EBIT growth 5Y6.28%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-137.84%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-104.15%

OCF growth 3YN/A

OCF growth 5YN/A

PASSAT (PSAT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens